DuPont planning to sell its Medical Products businesses.
This article was originally published in The Gray Sheet
Executive Summary
DUPONT $535 MIL. X-RAY AND IMAGING BUSINESS FOR SALE through J.P. Morgan & Co. as part of DuPont's May 19 announced plan to exit the medical products sector. The x-ray/imaging business, with an estimated 3,000 employees, is the largest of four components which are being put up for sale. The other units being divested are In-vitro Diagnostics ($335 mil.); New England Nuclear research products ($110 mil.); and Sorvall Centrifuges ($75 mil.).